Older participants are frequently excluded from Parkinson's disease research
Keywords: پارکینسون; Parkinson's; Ageism; Research; Elderly; Exclusion;
مقالات ISI پارکینسون (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Folding and misfolding of alpha-synuclein on membranes
Keywords: پارکینسون; Alpha-synuclein; Parkinson's; Amyloid; Membrane; Aggregation
The search for genetic mouse models of prodromal Parkinson's disease
Keywords: پارکینسون; Parkinson's; PINK1; Genetic disease; Cognition; Gait; Olfaction; Mitochondria; 5-HT;
Current status and future directions of gene expression profiling in Parkinson's disease
Keywords: پارکینسون; Parkinson's; Gene expression; Microarray; Pathogenesis; Mitochondria; Axon; Axon guidance; Synaptic function; Synuclein;
Signal transduction pathway activity compensates dopamine D2/D3 receptor density changes in Parkinson's disease: a preliminary comparative human brain receptor autoradiography study with [3H]raclopride and [35S]GTPγS
Keywords: پارکینسون; ARG; autoradiography; DAT; dopamine transporter; GTPγS; guanosine 5â²-O-[gamma-thio]triphosphate; l-DOPA; L-3,4-dihydroxyphenylalanine; MAO-B; Monoamine oxidase B; MPTP; 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; OD; optical density; PD; Parkinson's
In vitro and in vivo iontophoretic transdermal delivery of an anti-parkinsonian agent
Keywords: پارکینسون; Iontophoresis; Transdermal; SLV 318; Parkinson's; Pharmacokinetics; Counter-ions
Return of bradykinesia after subthalamic stimulation ceases: Relationship to electrode location
Keywords: پارکینسون; Parkinson's; Deep brain stimulation; Subthalamic nucleus; Zona incerta; Plasticity
Role of paraoxonase 1 (PON1) in organophosphate metabolism: Implications in neurodegenerative diseases
Keywords: پارکینسون; Paraoxonase 1; Organophosphate pesticides; Parkinson's; Alzheimer's; Polymorphism
Classifier ensemble construction with rotation forest to improve medical diagnosis performance of machine learning algorithms
Keywords: پارکینسون; Rotation forest; Ensemble learning; Classifier performance; Parkinson's; Diabetes; Cleveland heart; Computer aided diagnosis
Assessing the role of dopamine in limb and cranial-oromotor control in a rat model of Parkinson's disease
Keywords: پارکینسون; Parkinson's; 6-OHDA; Rat; Oromotor; Oral motor; Mastication; Limb use; Ultrasonic vocalizations; Exercise; Pasta
Role of ubiquitin–proteasome-mediated proteolysis in nervous system disease
Keywords: پارکینسون; Neurodegenerative disease; Mental disorders; Synaptic plasticity; Therapeutic targets; Alzheimer’s; Parkinson's
Neurologic Manifestations of Chronic Methamphetamine Abuse
Keywords: پارکینسون; Methamphetamine abuse; Psychosis; Parkinson's; Choreoathetoid; Punding; Formication;
Therapy adherence issues in Parkinson's disease
Keywords: پارکینسون; Therapeutics; Adherence; Compliance; Parkinson's
Melatonin is released in the third ventricle in humans. A study in movement disorders
Keywords: پارکینسون; Melatonin; Cerebrospinal fluid; aMT6s; Neurosurgery; Human; Parkinson's;
DnaK/DnaJ/GrpE of Hsp70 system have differing effects on α-synuclein fibrillation involved in Parkinson's disease
Keywords: پارکینسون; PD, Parkinson's disease; α-Syn, alpha-synuclein; ThT, Thioflavin T; Hsp70, heat shock protein 70; RCMLA, reduced carboxymethylated lactalbumin; TMAO, triethylamine N-oxideα-Synuclein; Chaperones; DnaK; DnaJ; GrpE; Parkinson's; Amyloid
Tumor necrosis factor-alpha mediated signaling in neuronal homeostasis and dysfunction
Keywords: پارکینسون; TNF-α; Neuroinflammation; Alzheimer's; Parkinson's; Synaptic plasticity; Ionic homeostasis
RNAi therapeutics for CNS disorders
Keywords: پارکینسون; RNAi; Therapy; Neurodegenerative; Huntington's; Alzheimer's; Parkinson's; Ataxias
An in vivo pharmacological evaluation of pardoprunox (SLV308) — A novel combined dopamine D2/D3 receptor partial agonist and 5-HT1A receptor agonist with efficacy in experimental models of Parkinson's disease
Keywords: پارکینسون; Pardoprunox (SLV308); Dopamine D2/D3 partial agonist; 5-HT1A agonist; MPTP; Parkinson's
Community-based rehabilitation for Parkinson's disease: From neurons to neighborhoods
Keywords: پارکینسون; Neuroplasticity; Exercise; Parkinson's; Community-based research
The CB1 antagonist rimonabant is adjunctively therapeutic as well as monotherapeutic in an animal model of Parkinson's disease
Keywords: پارکینسون; Parkinson's; 6-OHDA; Rimonabant; CB1 receptors; l-DOPA; Forepaw stepping
E46K Parkinson’s-Linked Mutation Enhances C-Terminal-to-N-Terminal Contacts in α-Synuclein
Keywords: پارکینسون; PD, Parkinson's disease; αS, α-synuclein; PRE, paramagnetic relaxation enhancement; WT, wild type; RDC, residual dipolar coupling; HSQC, heteronuclear single quantum coherence; NIH, National Institutes of Healthsynuclein; Parkinson's; amyloid; protein agg
Interrupting the inflammatory cycle in chronic diseases - Do gap junctions provide the answer?
Keywords: پارکینسون; Connexin; Neurodegenerative disease; Cardiovascular disease; Parkinson's; Huntington's; Alzheimer's; Epilepsy; Diabetes; Obesity; Chronic inflammation; Inflammatory cytokines; Gap junctions;
Use of non-mammalian alternative models for neurotoxicological study
Keywords: پارکینسون; C. elegans; Parkinson's; Zebrafish; Neurotoxicological studies; Insects; Insecticides
Dystrophic serotonergic axons in neurodegenerative diseases
Keywords: پارکینسون; Degeneration; Neuropathology; Parkinson's; Lewy-body; Frontal lobe dementia; Aging; Postmortem; Hippocampus; Prefrontal; Entorhinal; Substantia nigra; Human;
No association between Parkinson's disease and three polymorphisms in the eNOS, nNOS, and iNOS genes
Keywords: پارکینسون; Parkinson's; Nitric oxide synthases; DNA polymorphisms; Mitochondria
Motor deficits and altered striatal gene expression in aphakia (ak) mice
Keywords: پارکینسون; Ache; acetylcholinesterase; ak; aphakia; DA; dopamine; Drd; dopamine receptor; Chrm; cholinergic muscarinic; Chrn; cholinergic nicotinic; Comt; catechol-o-methyl transferase; GAPDH; glyceraldehyde-3-phosphate dehydrogenase; Maoa; monoamine oxidase A; MPTP
Validation studies of the human movement analysis panel for hand/arm performance
Keywords: پارکینسون; Motor measurement; Motor assessment; Motor quantitation; Movement; Upper extremity; Hand; Parkinson's; Human
Transgenic animal models of neurodegenerative diseases and their application to treatment development
Keywords: پارکینسون; Transgenic; Models; Neurodegenerative disease; Aging; Alzheimer's; Parkinson's; Lewy bodies; MSA
6-Hydroxydopamine induces cystatin C-mediated cysteine protease suppression and cathepsin D activation
Keywords: پارکینسون; Cystatin C; Parkinson's; Cathepsin; 6-OHDA; PC12 cells; Neurodegeneration
Deep brain stimulation in neurologic disorders
Keywords: پارکینسون; Deep brain stimulation; Parkinson's; Essential tremor; Dystonia; Tourette syndrome; Epilepsy; Obsessive-compulsive; Depression
Enhancing tyrosine hydroxylase expression and survival of fetal ventral mesencephalon neurons with rat or porcine Sertoli cells in vitro
Keywords: پارکینسون; Parkinson's; Development; Cell culture; Dopaminergic neurons;
Enhanced cystatin C and lysosomal protease expression following 6-hydroxydopamine exposure
Keywords: پارکینسون; 6-Hydroxydopamine (6-OHDA); Parkinson's; Cystatin C; Apoptosis; Pheochromocytoma cells (PC12); Lysosomal proteases
Is the functional decline of Parkinson's disease similar to the functional decline of Alzheimer's disease?
Keywords: پارکینسون; Cognitive decline; Parkinson's; Alzheimer's; Function;
Combined blockade of AMPA and NMDA glutamate receptors reduces levodopa-induced motor complications in animal models of PD
Keywords: پارکینسون; AMPA; NMDA; Parkinson's; Dyskinesias; Levodopa;